WILLEM OVERWIJK's research topics

WILLEM OVERWIJK

Concepts (463)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with WILLEM OVERWIJK's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that WILLEM OVERWIJK has written about over time.

Antigens, Neoplasm, 17 publications between 1997 and 2017, average publication date May 2004. Immunotherapy, Active, 3 publications between 1997 and 2015, average publication date August 2004. Immune Tolerance, 8 publications between 1998 and 2017, average publication date April 2007. Cancer Vaccines, 28 publications between 1997 and 2018, average publication date June 2007. Autoimmunity, 3 publications between 1999 and 2020, average publication date November 2007. gp100 Melanoma Antigen, 10 publications between 1997 and 2018, average publication date February 2008. Antigen Presentation, 6 publications between 1997 and 2018, average publication date November 2008. CD8-Positive T-Lymphocytes, 31 publications between 1998 and 2022, average publication date March 2010. Melanoma, Experimental, 23 publications between 1999 and 2022, average publication date November 2010. Neoplasms, 20 publications between 1997 and 2021, average publication date May 2011. T-Lymphocytes, Regulatory, 9 publications between 1998 and 2020, average publication date September 2011. Peptides, 6 publications between 2000 and 2019, average publication date October 2011. Interleukin-2, 12 publications between 1998 and 2021, average publication date March 2012. Melanoma, 28 publications between 1997 and 2022, average publication date November 2012. T-Lymphocytes, 21 publications between 1999 and 2023, average publication date January 2013. Immunotherapy, 22 publications between 1997 and 2023, average publication date September 2014. Immune System, 2 publications between 2012 and 2017, average publication date April 2015. CTLA-4 Antigen, 7 publications between 2014 and 2022, average publication date May 2017. Tumor Microenvironment, 13 publications between 2011 and 2023, average publication date July 2017. Bioengineering, 1 publications between 2020 and 2020, average publication date November 2020.

Antigens, Neoplasm
Immunotherapy, Active
Immune Tolerance
Cancer Vaccines
Autoimmunity
gp100 Melanoma Antigen
Antigen Presentation
CD8-Positive T-Lymphocytes
Melanoma, Experimental
Neoplasms
T-Lymphocytes, Regulatory
Peptides
Interleukin-2
Melanoma
T-Lymphocytes
Immunotherapy
Immune System
CTLA-4 Antigen
Tumor Microenvironment
Bioengineering

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Antigens, Neoplasm	17	1997	2017	May 2004
Immunotherapy, Active	3	1997	2015	August 2004
Immune Tolerance	8	1998	2017	April 2007
Cancer Vaccines	28	1997	2018	June 2007
Autoimmunity	3	1999	2020	November 2007
gp100 Melanoma Antigen	10	1997	2018	February 2008
Antigen Presentation	6	1997	2018	November 2008
CD8-Positive T-Lymphocytes	31	1998	2022	March 2010
Melanoma, Experimental	23	1999	2022	November 2010
Neoplasms	20	1997	2021	May 2011
T-Lymphocytes, Regulatory	9	1998	2020	September 2011
Peptides	6	2000	2019	October 2011
Interleukin-2	12	1998	2021	March 2012
Melanoma	28	1997	2022	November 2012
T-Lymphocytes	21	1999	2023	January 2013
Immunotherapy	22	1997	2023	September 2014
Immune System	2	2012	2017	April 2015
CTLA-4 Antigen	7	2014	2022	May 2017
Tumor Microenvironment	13	2011	2023	July 2017
Bioengineering	1	2020	2020	November 2020

OVERWIJK's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (463)

Explore

Co-Authors (109)

Explore

Similar People (60)

Explore

Same Department

Explore